Delivery Order SPE2DB22D2211-SPE2DB25FSDMD
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for PREVYMIS 480 mg tablets (seven-count package) valued at $4,719.34 under a firm fixed-price arrangement. The award was issued on August 22, 2025, with an ultimate completion date of September 15, 2025. No set-aside designation was applied to this competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,719.34 firm fixed-price delivery order is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 MG tablets in a quantity of 7 units, valued at $9,438.70. This is a firm fixed price delivery order issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, and the place of performance...
- This federal contract award is for the delivery of PREVYMIS 480 MG TABLET 7S to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,427.74 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 25, 2024. The contract has an ultimate completion date of October 17, 2024 and is not set aside for any specific business type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- This is a delivery order issued under a $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp's Corporate Office Division and the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $4,427.74, is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,427.74, is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,719.34 firm fixed price delivery order is for PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,438.70 fixed-price delivery order is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is a $4,719.34 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a medication, with a performance period extending through June 25, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a delivery order valued at $4,719.34 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, with a period of performance extending through July 2, 2025. The contract is designated as non-set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDMDDelivery Order
This delivery order, awarded August 22, 2025, to AmerisourceBergen Drug Corp represents a $4,719.34 firm fixed-price award for the supply of PREVYMIS 480 mg tablets (quantity 7) to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through December 2026. The contract involves no set-aside designation and was competitively awarded, with performance scheduled for completion by September 15, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for the DLA's Medical Supply Chain, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This specific delivery order for PREVYMIS, an antiviral medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for federal healthcare programs, with the transaction processed through the DLA's comprehensive global pharmaceutical support vehicle that enables flexible delivery of critical medical commodities to Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/22/25 |